Indaptus Therapeutics (INDP) Operating Expenses (2020 - 2026)
Indaptus Therapeutics (INDP) posted quarterly Operating Expenses of $2.2 million for Q1 2026, down 52.77% year-over-year from $4.6 million in Q1 2025, and down 73.52% quarter-over-quarter from $8.2 million in Q4 2025.
Indaptus Therapeutics (INDP) Operating Expenses (2020 - 2026) Analysis & Trends
Indaptus Therapeutics' Operating Expenses history runs 7 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 52.77% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $17.4 million (up 8.91% YoY), while the FY2025 annual figure was $19.8 million, up 29.08% from the prior year.
- Operating Expenses for Q1 2026 stood at $2.2 million, down from $8.2 million in the prior quarter.
- The five-year high for Operating Expenses was $8.2 million in Q4 2025, with the low at $2.2 million in Q1 2026.
- The 5-year median for Operating Expenses is $4.1 million (2022), against an average of $4.0 million.
- The sharpest annual moves came in 2022 and 2026: Operating Expenses surged 631.92% in 2022, then plunged 52.77% in 2026.
- Indaptus Therapeutics' Operating Expenses stood at $4.1 million in 2022, then advanced by 2.27% to $4.2 million in 2023, then slipped by 0.19% to $4.2 million in 2024, then jumped by 95.51% to $8.2 million in 2025, then slumped by 73.52% to $2.2 million in 2026.
- Business Quant data shows INDP's Operating Expenses at $2.2 million in Q1 2026, $8.2 million in Q4 2025, and $2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | Indaptus Therapeutics | 146.91 Mn | 135.35 Mn | - | 1.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.81 Mn |
| Mar 31, 2026 | 2.16 Mn |
| Dec 31, 2025 | 8.16 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Jun 30, 2025 | 4.46 Mn |
| Mar 31, 2025 | 4.57 Mn |
| Dec 31, 2024 | 4.17 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 4.11 Mn |
| Mar 31, 2024 | 3.94 Mn |
| Dec 31, 2023 | 4.18 Mn |
| Sep 30, 2023 | 4.25 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 4.46 Mn |
| Dec 31, 2022 | 4.09 Mn |
| Sep 30, 2022 | 3.55 Mn |
| Jun 30, 2022 | 3.87 Mn |
| Mar 31, 2022 | 3.40 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 3.37 Mn |